Coexistence of Myeloproliferative Neoplasm and Plasma-Cell Dyscrasia

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.09.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Japanese Plasma Cell Dyscrasia Syndrome: Case Report and Theory of Pathogenesis

Postgraduate Medical Journal
Medicine
1982English

Successful Therapy of Pure Red Cell Aplasia Secondary to Plasma Cell Dyscrasia With Bolus Methylprednisolone.

Internal Medicine
Internal MedicineMedicine
2001English

Systemic Notch Downregulation Promotes Kras G12D ‐induced Myeloproliferative Neoplasm

British Journal of Haematology
Hematology
2019English

Plasma Cell Dyscrasia With Polyneuritis and Dermato-Endocrine Alterations. Report of a New Case Outside Japan.

Postgraduate Medical Journal
Medicine
1980English

ETV6–FLT3 Fusion Gene-Positive, Eosinophilia-Associated Myeloproliferative Neoplasm Successfully Treated With Sorafenib and Allogeneic Stem Cell Transplant

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

Sequential B-Lymphoid and Myeloid Blastic Transformation of Philadelphia Chromosome-Negative Myeloproliferative Neoplasm

British Journal of Haematology
Hematology
2018English

Atypical Chronic Myeloid Leukaemia – A Rare Subtype of Myelodysplastic/Myeloproliferative Neoplasm

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2018English

Erythrocyte-Derived Microvesicles Induce Arterial Spasms in JAK2V617F Myeloproliferative Neoplasm

Journal of Clinical Investigation
Medicine
2020English

Critical Appraisal of the Role of Ruxolitinib in Myeloproliferative Neoplasm-Associated Myelofibrosis

OncoTargets and Therapy
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy